Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 5Recruiting 2Withdrawn 1Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 23Gynecologic 4Gastrointestinal 4Other solid neoplasm 2Head & Neck 2Endocrine 2NET 1Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 370Head and Neck Neoplasms 356Nasopharyngeal Carcinoma 140Thyroid Neoplasms 124Carcinoma, Non-Small-Cell Lung 93Mouth Neoplasms 84Melanoma 76Breast Neoplasms 75Oropharyngeal Neoplasms 72Colorectal Neoplasms 68Uterine Cervical Neoplasms 66Lung Neoplasms 66Neoplasms 63Ovarian Neoplasms 61Neoplasm Metastasis 52Prostatic Neoplasms 51Stomach Neoplasms 49Pancreatic Neoplasms 47Carcinoma, Squamous Cell 45Triple Negative Breast Neoplasms 43Laryngeal Neoplasms 42Esophageal Neoplasms 42Endometrial Neoplasms 42Thyroid Nodule 37Carcinoma, Renal Cell 37Urinary Bladder Neoplasms 36Sarcoma 34Recurrence 31Carcinoma 30Nasopharyngeal Neoplasms 28

Interventions

zimberelimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Thymoma × Head & Neck × Clear all
NCT06790706 2025-10-06

IMMUNORARE5

Hospices Civils de Lyon

Phase 2 Recruiting
154 enrolled
EndocrineGastrointestinalGynecologicHead & NeckNETThoracic

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Thymoma, Gestational Trophoblastic Disease, Thyroid Carcinoma, Anaplastic

NCT07181720 2025-10-02

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

Chongqing Precision Biotech Co., Ltd

Phase 1 Recruiting
90 enrolled
EndocrineGenitourinaryGynecologicHead & NeckThoracic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Thymoma, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡